# FDA Inspection 1092876 - Kazimierz Kuliczkowski, M.D. - May 16, 2019

Source: https://www.keypedia.com/records/fda_inspections/kazimierz-kuliczkowski-md/7bc14b38-8108-499b-bcdb-d0552e5d878b
Source feed: FDA_Inspections

> FDA Inspection 1092876 for Kazimierz Kuliczkowski, M.D. on May 16, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1092876
- Company Name: Kazimierz Kuliczkowski, M.D.
- Inspection Date: 2019-05-16
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 950460 - 2015-11-19](https://www.keypedia.com/records/fda_inspections/kazimierz-kuliczkowski-md/2807bfb3-ff09-411a-8bf8-53a0ac4965e5)
- [FDA Inspection 943959 - 2015-09-18](https://www.keypedia.com/records/fda_inspections/kazimierz-kuliczkowski-md/9c4f5349-627b-48cb-930b-ad46cb886d39)

Company: https://www.keypedia.com/companies/kazimierz-kuliczkowski-md/0f100ffa-487d-4f8f-8bed-1a1b5acd5f72

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c